Indications |
Oral Acute diarrhoea Adult: Initial dose: 10 mg, followed by 5 mg every 6 hr. Child: >12 yr: 5 mg tid; 9-12 yr: 2.5 mg 4 times daily; 4-8 yr: 2.5 mg tid. Oral Chronic diarrhoea Adult: Initial dose: 10 mg followed by 5 mg every 6 hr. Discontinue use if no clinical improvement is noted after 10 days of continuous usage at 20 mg/day. Max: 20 mg/day. |
Contraindications |
Infants and children <4 yr. Jaundice, intestinal obstruction. Diarrhoea associated with pseudomembranous colitis or enterotoxin-producing bacteria. |
Warnings / Precautions |
Hepatic dysfunction, inflammatory bowel disease. Pregnancy, lactation; young children. |
Adverse Reactions |
GI effects; headache, drowsiness, dizziness, restlessness, euphoria, depression, numbness of the extremities; hypersensitivity reactions, swelling of the gums. |
Overdose Reactions |
Symptoms: Atropinism may persist for 2-3 hr (e.g. high fever, generalised flushing, and tachypnoea). Drowsiness, miosis, hypotonia, loss of tendon reflexes, nystagmus, and seizures followed by respiratory depression and total apnoea may manifest 12-30 hr after drug ingestion. Treatment: empty stomach by emesis or by gastric lavage. Gastric lavage may be effective even after several hr due to decreased GI motility and pylorospasm. Treatment is supportive and symptomatic and monitor closely for 48 hr. Naloxone may be useful in the treatment of severe respiratory depression. |
Drug Interactions |
Potentiates effects of other CNS depressants (alcohol, barbiturates) and some anxiolytics. Potentially Fatal: Theoretical hypertensive crisis with MAOIs. See Below for More diphenoxylate Drug Interactions |
Mechanism of Actions |
Diphenoxylate is a synthetic derivative of pethidine with little or no analgesic activity. It reduces intestinal motility and excessive GI propulsion by acting on the smooth muscle of the intestinal tract. Onset: 45 min to 1 hr. Duration: 3-4 hr. Absorption: Well absorbed from the GI tract. Distribution: May distribute into breast milk. Metabolism: Rapidly and extensively metabolised in the liver. Excretion: Excreted mainly as metabolites and their conjugates in the faeces. |
Administration |
May be taken with or without food. |
ATC Classification |
A07DA01 - diphenoxylate ; Belongs to the class of antipropulsives. Used in the treatment of diarrhea. |
Available As |
|
Diphenoxylate
Post Review about Diphenoxylate Click here to cancel reply.
Diphenoxylate Containing Brands
Diphenoxylate is used in following diseases
Drug - Drug Interactions of Diphenoxylate
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.